Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like Most Class I Device Recall Notices Lack Key Identification Numbers, Study Says May 15, 2023 FDA Releases Product-Specific Guidances to Foster Generic Competition September 13, 2018 Jubilant Pharma Draws Form 483 for Inadequate Batch Failure Investigations October 26, 2022